The historical rank and industry rank for Eurofins Scientific SE's Days Payable or its related term are showing as below:
ERFSF'
s Days Payable Range Over the Past 10 Years
Min: 86.85 Med: 99.33 Max: 105.87
Current: 103.88
During the past 13 years, Eurofins Scientific SE's highest Days Payable was 105.87. The lowest was 86.85. And the median was 99.33.
ERFSF's Days Payable is ranked better than 64.92% of 191
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.87
vs ERFSF: 103.88
Eurofins Scientific SE's Days Payable
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Eurofins Scientific SE Days Payable Related Terms
Eurofins Scientific SE Days Payable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Days Payable distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Eurofins Scientific SE's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE (ERFSF) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Eurofins Scientific SE and its competitors. Over the past decade, Eurofins Scientific SE's Days Payable has ranged from 86.85 to 105.87. According to the industry distribution chart, Eurofins Scientific SE ranks #67 out of 191 companies in the Medical Diagnostics & Research industry, placing it in the top 35.1%.
Is Eurofins Scientific SE's Days Payable too high?
Eurofins Scientific SE's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 86.85 to a high of 105.87. Based on the distribution chart, Eurofins Scientific SE ranks #67 out of 191 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #67 out of 191 companies for Days Payable. This puts Eurofins Scientific SE in the upper half of its industry. The industry median Days Payable is 68.87. Historically, Eurofins Scientific SE's own Days Payable has ranged from 86.85 to 105.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 68.87, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 68.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $76.00, compared to a current price of $76.03 — trading 0% above its estimated fair value. The current Days Payable is 0.00. Eurofins Scientific SE's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $76.03 is trading 0% above its estimated GF Value™ of $76.00.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
Days Payable: 0.00
GF Value™: $76.00 vs. price of $76.03 (0% above fair value)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
81GF Score
Get the complete analysis for ERFSF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 
